AbbVie (ABBV) EBIT Margin (2012 - 2026)
AbbVie's EBIT Margin came in at 37.86% for Q2 2026, up 6.13 percentage points from 31.73% a year earlier and up 11.26 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBIT Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AbbVie reported EBIT Margin of 26.20%, up 7.40 percentage points year-over-year; for FY2025, it was 24.65%, up 8.43 percentage points from FY2024.
- EBIT Margin carries a five-year change of -0.16 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was 16.22% in FY2024 (-7.27 pp), 23.49% in FY2023 (-7.72 pp), 31.21% in FY2022 (-0.69 pp) and 31.89% in FY2021 (+7.09 pp).
- The Q2 2026 figure represents the highest quarterly EBIT Margin since Q1 2020.
- Year-over-year, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of +1.85 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2025 (a gain of 37.21 percentage points), and the weakest in Q4 2024 (a drop of 32.21 percentage points).
- Business Quant data shows ABBV's EBIT Margin at 26.60% (Q1 2026), 27.34% (Q4 2025) and 12.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 2.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.86% |
| Mar 31, 2026 | 26.60% |
| Dec 31, 2025 | 27.34% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 31.73% |
| Mar 31, 2025 | 27.98% |
| Dec 31, 2024 | -9.87% |
| Sep 30, 2024 | 26.49% |
| Jun 30, 2024 | 27.64% |
| Mar 31, 2024 | 22.73% |
| Dec 31, 2023 | 22.34% |
| Sep 30, 2023 | 16.38% |
| Jun 30, 2023 | 32.55% |
| Mar 31, 2023 | 22.64% |
| Dec 31, 2022 | 36.39% |
| Sep 30, 2022 | 31.08% |
| Jun 30, 2022 | 22.59% |
| Mar 31, 2022 | 34.84% |
| Dec 31, 2021 | 34.09% |
| Sep 30, 2021 | 30.02% |
API Access
AbbVie EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();